NSE: PGHH - Procter & Gamble Hygiene and Health Care Limited

Yield per half year: -16.9%
Dividend yield: +2.06%
Sector: Consumer Staples

Company Analysis Procter & Gamble Hygiene and Health Care Limited

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Dividends (2.06%) are higher than the sector average (1.57%).
  • The company's current efficiency (ROE=78.45%) is higher than the sector average (ROE=20.22%)

Disadvantages

  • Price (13597.25 β‚Ή) is higher than fair price (2624.15 β‚Ή)
  • The stock's return over the last year (-13.76%) is lower than the sector average (-8.99%).
  • Current debt level 0.1657% has increased over 5 years from 0.1281%.

Similar companies

NestlΓ© India Limited

Dabur India Limited

Britannia Industries Limited

Hindustan Unilever Limited

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

Procter & Gamble Hygiene and Health Care Limited Consumer Staples Index
7 days -1.9% -2.3% -2.3%
90 days -13.6% -11.9% -10%
1 year -13.8% -9% -1.2%

PGHH vs Sector: Procter & Gamble Hygiene and Health Care Limited has slightly underperformed the "Consumer Staples" sector by -4.77% over the past year.

PGHH vs Market: Procter & Gamble Hygiene and Health Care Limited has significantly underperformed the market by -12.58% over the past year.

Stable price: PGHH is not significantly more volatile than the rest of the market on "National Stock Exchange Of India" over the last 3 months, with typical variations of +/- 5% per week.

Long period: PGHH with weekly volatility of -0.2646% over the past year.

3. Summary of the report

3.1. General

P/E: 77.35
P/S: 12.42

3.2. Revenue

EPS 207.95
ROE 78.45%
ROA 33.79%
ROIC 161.92%
Ebitda margin 24.31%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (13597.25 β‚Ή) is higher than the fair price (2624.15 β‚Ή).

Price is higher than fair: The current price (13597.25 β‚Ή) is 80.7% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (77.35) is higher than that of the sector as a whole (44.35).

P/E vs Market: The company's P/E (77.35) is higher than that of the market as a whole (64.67).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (67.39) is higher than that of the sector as a whole (9.51).

P/BV vs Market: The company's P/BV (67.39) is higher than that of the market as a whole (6.36).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (12.42) is higher than that of the sector as a whole (4.36).

P/S vs Market: The company's P/S indicator (12.42) is lower than that of the market as a whole (18.79).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (50.5) is higher than that of the sector as a whole (28.28).

EV/Ebitda vs Market: The company's EV/Ebitda (50.5) is higher than that of the market as a whole (34.46).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 11.17% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (11.17%).

Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (6.98%).

5.4. ROE

ROE vs Sector: The company's ROE (78.45%) is higher than that of the sector as a whole (20.22%).

ROE vs Market: The company's ROE (78.45%) is higher than that of the market as a whole (3.59%).

5.5. ROA

ROA vs Sector: The company's ROA (33.79%) is higher than that of the sector as a whole (10.15%).

ROA vs Market: The company's ROA (33.79%) is higher than that of the market as a whole (7.91%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (161.92%) is higher than that of the sector as a whole (22.6%).

ROIC vs Market: The company's ROIC (161.92%) is higher than that of the market as a whole (15.54%).

6. Finance

6.1. Assets and debt

Debt level: (0.1657%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 0.1281% to 0.1657%.

Debt Covering: The debt is covered by 0.4563% from net profit.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

High yield: The dividend yield of the company 2.06% is higher than the average for the sector '1.57%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 2.06% has been steadily paid over the past 7 years, DSI=0.93.

Weak dividend growth: The company's dividend yield 2.06% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.

7.3. Payout percentage

Dividend Coverage: Current payments from income (127.43%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

No insider transactions have been recorded yet

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Procter & Gamble Hygiene and Health Care Limited

9.3. Comments